Corporate News

Find all the latest news from our corporate headquarters in New Brunswick, New Jersey.

< Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next >

New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc.

September 12, 2012

Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

September 05, 2012

Janssen Pharmaceuticals, Inc. announces RISPERDAL® consumer protection settlement with 36 states and the District of Columbia

August 30, 2012

Johnson & Johnson Announces Discontinuation Of Phase 3 Development of Bapineuzumab Intravenous (IV) In Mild-To-Moderate Alzheimer's Disease

August 06, 2012

Johnson & Johnson Reports 2012 Second-Quarter Results

July 17, 2012

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2012

July 16, 2012

< Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.